中银证券给予益丰药房买入评级业绩稳健增长各区域门店扩张持续推进

每日经济新闻11-09

中银证券11月09日发布研报称，给予益丰药房（603939.SH，最新价：25.83元）买入评级。评级理由主要包括：1）收入端与利润端均保持稳健增长，毛利率实现同比提升；2）各区域收入均保持稳健增长，批发及零售业务均保持正向增长。风险提示：行业政策变动风险，门店拓展不及预期风险，新店培育不及预期风险。AI点评：益丰药房近一个月获得7份券商研报关注，买入5家。文章来源：每日经济新闻原标题：中银证券...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2482419883?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-09 14:40","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2482419883","market":"sh","top_or_hot":-1,"title":"中银证券给予益丰药房买入评级 业绩稳健增长 各区域门店扩张持续推进","media":"每日经济新闻","content":"<div>\n<p>中银证券11月09日发布研报称，给予益丰药房（603939.SH，最新价：25.83元）买入评级。评级理由主要包括：1）收入端与利润端均保持稳健增长，毛利率实现同比提升；2）各区域收入均保持稳健增长，批发及零售业务均保持正向增长。风险提示：行业政策变动风险，门店拓展不及预期风险，新店培育不及预期风险。AI点评：益丰药房近一个月获得7份券商研报关注，买入5家。文章来源：每日经济新闻原标题：中银证券...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109145920a22686b4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>中银证券给予益丰药房买入评级 业绩稳健增长 各区域门店扩张持续推进</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n中银证券给予益丰药房买入评级 业绩稳健增长 各区域门店扩张持续推进\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-09 14:40 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109145920a22686b4&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>中银证券11月09日发布研报称，给予益丰药房（603939.SH，最新价：25.83元）买入评级。评级理由主要包括：1）收入端与利润端均保持稳健增长，毛利率实现同比提升；2）各区域收入均保持稳健增长，批发及零售业务均保持正向增长。风险提示：行业政策变动风险，门店拓展不及预期风险，新店培育不及预期风险。AI点评：益丰药房近一个月获得7份券商研报关注，买入5家。文章来源：每日经济新闻原标题：中银证券...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109145920a22686b4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"603939","symbol_name":"益丰药房","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109145920a22686b4&s=b","article_id":"2482419883","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109145920a22686b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2482419883","pubTimestamp":1731134454,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"中银证券11月09日发布研报称，给予益丰药房（603939.SH，最新价：25.83元）买入评级。评级理由主要包括：1）收入端与利润端均保持稳健增长，毛利率实现同比提升；2）各区域收入均保持稳健增长，批发及零售业务均保持正向增长。风险提示：行业政策变动风险，门店拓展不及预期风险，新店培育不及预期风险。AI点评：益丰药房近一个月获得7份券商研报关注，买入5家。文章来源：每日经济新闻原标题：中银证券给予益丰药房买入评级，业绩稳健增长，各区域门店扩张持续推进","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["rate"],"viewcount":null,"language":"zh","relate_stocks":{"601696":"中银证券","603939":"益丰药房"},"translate_title":"Bank of China Securities gives Yifeng Pharmacy a buy rating, its performance is growing steadily, and store expansion in various regions continues to advance","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601696":1,"603939":1},"content_text":"中银证券11月09日发布研报称，给予益丰药房（603939.SH，最新价：25.83元）买入评级。评级理由主要包括：1）收入端与利润端均保持稳健增长，毛利率实现同比提升；2）各区域收入均保持稳健增长，批发及零售业务均保持正向增长。风险提示：行业政策变动风险，门店拓展不及预期风险，新店培育不及预期风险。AI点评：益丰药房近一个月获得7份券商研报关注，买入5家。文章来源：每日经济新闻原标题：中银证券给予益丰药房买入评级，业绩稳健增长，各区域门店扩张持续推进","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Business Data","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2482419883"}

中银证券给予益丰药房买入评级 业绩稳健增长 各区域门店扩张持续推进

精彩评论

中银证券给予益丰药房买入评级业绩稳健增长各区域门店扩张持续推进